USD 0.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | 48 Thousand |
Gross Profit | - | - | - | - | - | -48 Thousand |
Operating Expenses | - | - | - | - | - | 12.32 Million |
Selling, General and Administrative Expenses | - | - | - | - | - | 12.32 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | 4.76 Million |
Cost and Expenses | - | - | - | - | - | 12.37 Million |
Operating Income | - | - | - | - | - | -25.68 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | - | - | - | - | 13.91 Million |
Earnings before Tax | - | - | - | - | - | -21.52 Million |
Net Income | - | - | - | - | - | -21.52 Million |
Earnings Per Share Basic | - | - | - | - | - | -0.99 |
Earnings Per Share Diluted | - | - | - | - | - | -0.99 |
Weighted Average Shares Outstanding | - | - | - | - | - | 21.76 Million |
Weighted Average Shares Outstanding (Diluted) | - | - | - | - | - | 21.76 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | -8.16 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2018 FY | 2016 FY |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | 48 Thousand |
Gross Profit | - | - | - | - | - | -48 Thousand |
Operating Expenses | - | - | - | - | - | 12.32 Million |
Selling, General and Administrative Expenses | - | - | - | - | - | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | 4.76 Million |
Cost and Expenses | - | - | - | - | - | 12.37 Million |
Operating Income | - | - | - | - | - | -25.68 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | - | - | - | - | 13.91 Million |
Earnings before Tax | - | - | - | - | - | -21.52 Million |
Net Income | - | - | - | - | - | -21.52 Million |
Earnings Per Share Basic | - | - | - | - | - | - |
Earnings Per Share Diluted | - | - | - | - | - | - |
Weighted Average Shares Outstanding | - | - | - | - | - | 21.76 Million |
Weighted Average Shares Outstanding (Diluted) | - | - | - | - | - | 21.76 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - |
Earnings Before Tax Margin | - | - | - | - | - | - |
FSTR
TOP-R
BALPHARMA
0I8F
000810
9225